Carl DeSelm
Associate Professor of Radiation Oncology · Washington University/B-JH/SLCH Consortium
Credentials: · · · · ·
History
Washington University School of Medicine in 2012
2000–2004
Research
Autophagy proteins regulate the secretory component of osteoclastic bone resorption
Developmental Cell · 2011 · First of 10 authors · 394 citations
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Cancer Cell · 2020 · 373 citations
Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape
Molecular Therapy · 2018 · First of 7 authors · 236 citations
- ST
6 papers
5 papers · 2 as a resident
4 papers
4 papers
4 papers · 3 as a resident
3 papers
3 papers
3 papers
Grants
- 2026–2028
Harnessing TLR4 Signaling Pathways in CAR Dendritic Cells to Overcome Tumor Immune Tolerance
National Cancer Institute · R21
Contact PI · $399.8K · Washington University
- 2021–2026
Re-Wiring PDAC Tumor Immunity Through Dendritic Cells
National Cancer Institute · R01
PI · $2.8M · Washington University
- 2018–2024
Immune Activating CAR-Modified Antigen Presenting Cells
NIH Office of the Director · DP5
Contact PI · $2M · Washington University
- 2009–2012
The Role of Paxillin in the Osteoclast
National Institute on Aging · F30
Contact PI · $102.6K · Washington University
Clinical trials
- 2021–2027
Principal investigator · Active not recruiting · Phase 2
Washington University School of Medicine
- 2026–2031
Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
Sub-investigator · Not yet recruiting · Phase 2
Washington University School of Medicine
- 2026–2030
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Sub-investigator · Recruiting · Phase 2
Washington University School of Medicine
- 2025–2026
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Sub-investigator · Recruiting
Washington University School of Medicine